Holzer & Holzer, LLC is investigating whether Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ: OBLN) complied with the federal securities laws. On January 23, 2018, Obalon announced it was terminating its upcoming stock offering. The Company disclosed that a whistleblower has alleged that Obalon improperly recognized revenue during the fourth quarter of 2017. The price of Obalon stock fell following the announcement.
If you purchased Obalon common stock and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer Esq. at cholzer@holzerlaw.com or Alexandria P. Rankin, Esq. at arankin@holzerlaw.com, or call the firm by toll-free telephone at (888) 508-6832.
Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180123006376/en/
Contacts:
Corey D. Holzer, Esq., 888-508-6832
(toll-free)
cholzer@holzerlaw.com
